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To the Editor,
I have recently read a reply letter by Dr. Berilgen
regarding my comments about his article published
in Seizure.1 However, I found that his/their replies/
comments to my letter were scientifically unaccep-
table. Here, I wish to expand upon his/their inter-
pretation of epileptic ghrelin levels. It seems he and
his co-workers are not aware of how peptides are
protected from protease degradation. Part of their
study involving measurement of ghrelin levels has
not been carried out properly.
Refering to his/their answer regarding distin-
guishing two forms of ghrelin with Phoenix’s Ghrelin
kit, they do not seem to know that Phoenix’s Ghrelin
(Human) RIA Kit detects total ghrelin, including
Ser3-octanoyl and Ser3-des-octanoyl ghrelins. As
mentioned by him/them this kit cannot separate
both forms of ghrelin at once. If this kit was capable
of distinguishing both forms, that would be excel-
lent because of reduced costs. To the best of my
knowledge, the only commercially available source
for active ghrelin (a lipopeptide) measurement is by
Linco Inc. (Cat.#: GHRA-88HK).
Referring to his/their answers regarding storage
and controversial results, ghrelin is relatively stable
when stored under cooled conditions. However,
addition of 10 ml aprotonin or phenylmethylsulfonyl
fluoride and 1/10 volume of 1N HCl per ml of sample
are necessary for accuracy and reliability, as
recently described for other peptides.2 Groschl
et al. showed that ghrelin level at 25 8C for >1
day significantly decreased compared with stored
at 4 8C.3 Therefore, carrying out a research project
where ‘how ghrelin levels were affected without
protease inhibitor’ is a big question. Again, when
compared their results with his cited reference 3,4 it
is very clear that their detected ghrelin levels were1059-1311/$ — see front matter # 2007 British Epilepsy Association
doi:10.1016/j.seizure.2007.03.009very low and reported ghrelin levels were still within
normal physiological condition. If so, it is not con-
vincing when they declare a link between epilepsy
and increased ghrelin levels. In addition, their
results were controversial when compared with
Greco et al. who found that ghrelin levels were
significantly lower than those of the patients who
did not even gain weight,5 thereby this issue needs
further investigation. It seems more detailed and
carefully designed and carried out experiments will
judge the controversial results of Dr. Berilgen et al.6References
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